Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-16

Clinical Trial Update: Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of a combination therapy with Differin Gel 0.3% and Duac (clindamycin/benzoyl peroxide) for acne vulgaris show results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Differin Gel 0.3%
  • Duac (benzoyl peroxide/adapalene)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2016-03-16